Boston Scientific Corp (BSX)vsCONMED Corporation (CNMD)
BSX
Boston Scientific Corp
$69.78
+2.39%
HEALTHCARE · Cap: $101.28B
CNMD
CONMED Corporation
$37.08
+1.42%
HEALTHCARE · Cap: $1.13B
Smart Verdict
WallStSmart Research — data-driven comparison
Boston Scientific Corp generates 1360% more annual revenue ($20.07B vs $1.37B). BSX leads profitability with a 14.4% profit margin vs 3.4%. BSX appears more attractively valued with a PEG of 0.75. BSX earns a higher WallStSmart Score of 63/100 (C+).
BSX
Buy63
out of 100
Grade: C+
CNMD
Hold49
out of 100
Grade: D+
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+1.2%
Fair Value
$70.62
Current Price
$69.78
$0.84 discount
Margin of Safety
-312.2%
Fair Value
$10.27
Current Price
$37.08
$26.81 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Large-cap with strong market position
Growing faster than its price suggests
15.9% revenue growth
Generating 1.0B in free cash flow
Reasonable price relative to book value
Areas to Watch
Premium valuation, high expectations priced in
Expensive relative to growth rate
Smaller company, higher risk/reward
ROE of 4.7% — below average capital efficiency
3.4% margin — thin
Comparative Analysis Report
WallStSmart ResearchBull Case : BSX
The strongest argument for BSX centers on Market Cap, PEG Ratio, Revenue Growth. Revenue growth of 15.9% demonstrates continued momentum. PEG of 0.75 suggests the stock is reasonably priced for its growth.
Bull Case : CNMD
The strongest argument for CNMD centers on Price/Book.
Bear Case : BSX
The primary concerns for BSX are P/E Ratio.
Bear Case : CNMD
The primary concerns for CNMD are PEG Ratio, Market Cap, Return on Equity. Thin 3.4% margins leave little buffer for downturns.
Key Dynamics to Monitor
BSX profiles as a growth stock while CNMD is a value play — different risk/reward profiles.
CNMD carries more volatility with a beta of 0.90 — expect wider price swings.
BSX is growing revenue faster at 15.9% — sustainability is the question.
BSX generates stronger free cash flow (1.0B), providing more financial flexibility.
Bottom Line
BSX scores higher overall (63/100 vs 49/100) and 15.9% revenue growth. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Boston Scientific Corp
HEALTHCARE · MEDICAL DEVICES · USA
Boston Scientific Corporation, doing business as Boston Scientific, is a manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology.
CONMED Corporation
HEALTHCARE · MEDICAL DEVICES · USA
CONMED Corporation, a medical technology company, develops, manufactures and sells surgical devices and related equipment for minimally invasive procedures worldwide. The company is headquartered in Largo, Florida.
Compare with Other MEDICAL DEVICES Stocks
Want to dig deeper into these stocks?